Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype

Diabetes Research and Clinical Practice

Volumn 83, Issue 3, 2009, Pages

  Cappelli, Alessia ^a,b   Tumini, Stefano ^c   Consoli, Agostino ^c   Carinci, Silvia ^c   Piersanti, Concettina ^d   Ruggiero, Giuseppina ^e   Simonella, Graziano ^f   Soletti, Filippo ^f   Staffolani, Paolo ^a   Pianese, Luigi ^a  

^a UO Laboratorio Analisi Cliniche e Microbiologiche   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Ospedale Civile   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f U O Diabetologia ed Endocrinologia   (Italy)

Author keywords

GCK; HNF1A; MODY; Mutation

Indexed keywords

GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; ITALY; MALE; MATURITY ONSET DIABETES MELLITUS; PHENOTYPE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; ALTERNATIVE SPLICING; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; FRAMESHIFT MUTATION; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; ITALY; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MUTATION, MISSENSE; PHENOTYPE; YOUNG ADULT;

EID: 59349087713     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.12.007     Document Type: Article

References (16)

1. Owen K., and Hattersley A.T. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 309-323
2. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (2007) 42-47
4. Boutin P., Vasseur F., Samson C., Wahl C., and Froguel P. Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination?. Diabetologia 44 (2001) 775-778
5. Anderson M.A., and Gusella J.F. Use of cyclosporin a in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro Cell. Dev. Biol. Plant 20 (1984) 856-858
6. Johansen A., Ek J., Mortensen H.B., Pedersen O., and Hansen T. Half of clinically defined Maturity-Onset Diabetes of the Young patients in Denmark do not have mutations in HNF4a, GCK, and TCF1. J. Clin. Endocrinol. Metab. 90 (2005) 4607-4614
7. Mahalingam B., Cuesta-Munoz A., Davis E.A., Matschinsky F.M., Harrison R.W., and Weber I.T. Structural model of human glucokinase in complex with glucose and ATP implications for the mutants that cause hypo- and hyperglycemia. Diabetes 48 (1999) 1698-1705
8. Chèvre J.C., Hani E.H., Boutin P., Vaxillaire M., Blanchè H., Vionnet N., et al. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 41 (1998) 1017-1023
9. Kaisaki P.J., Menzel S., Lindner T., Oda N., Rjasanowski I., Sahm J., et al. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46 (1997) 528-535
10. Harries L.W., Hattersley A.T., and Ellard S. Messenger RNA transcripts of the hepatocyte nuclear factor-1α gene containing premature termination codons are subject to nonsense-mediated decay. Diabetes 53 (2004) 500-504
11. Bulman M.P., Harries L.W., Hansen T., Shepherd M., Kelly W.F., Hattersley A.T., et al. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young. Diabetologia 45 (2002) 1463-1467
12. Harries L.W., Ellard S., Stride A., Morgan N.G., and Hattersley A.T. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum. Mol. Genet. 15 (2006) 2216-2224
13. Bellanné-Chantelot C., Carette C., Riveline J.P., Valero R., Gautier J.F., Larger E., et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 57 (2008) 503-508
14. Mantovani V., Salardi S., Cerreta V., Bastia D., Cenci M., Ragni L., et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum. Mutat. 22 (2003) 338
15. Massa O., Meschi F., Cuesta-Munoz A., Caumo A., Cerutti F., Toni S., et al. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia 44 (2001) 898-905
16. Murphy R., Ellard S., and Hattersley A.T. Clinical implications of a molecular genetic classification of monogenic β-cell diabetes, Nature Clinical Practice. Endocrinol. Metab. 4 (2008) 200-213